BRISTOL-MYERS SQUIBB COMPANY Restructuring Reserve
BRISTOL-MYERS SQUIBB COMPANY (BMY) had Restructuring Reserve of $150.00 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Liabilities
us-gaap:RestructuringReserve · last filed 2026-07-30
- 2026-06-30: Restructuring Reserve $150.00M.
- 2026-03-31: Restructuring Reserve $173.00M.
- 2025-12-31: Restructuring Reserve $315.00M.
- 2025-09-30: Restructuring Reserve $287.00M.
| Period end | Restructuring Reserve | Restructuring Reserve as first filed |
|---|---|---|
| 2026-06-30 | $150.00M 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $173.00M 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $315.00M 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $287.00M 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $353.00M 10-Q · filed 2026-07-30 | |
| 2025-03-31 | $288.00M 10-Q · filed 2026-04-30 | |
| 2024-12-31 | $297.00M 10-Q · filed 2026-07-30 | |
| 2024-09-30 | $314.00M 10-Q · filed 2025-10-30 | |
| 2024-06-30 | $431.00M 10-Q · filed 2025-07-31 | |
| 2024-03-31 | $309.00M 10-Q · filed 2025-04-24 | |
| 2023-12-31 | $188.00M 10-K · filed 2026-02-11 | |
| 2023-09-30 | $223.00M 10-Q · filed 2024-10-31 | |
| 2023-06-30 | $180.00M 10-Q · filed 2024-07-26 | |
| 2023-03-31 | $99.00M 10-Q · filed 2024-04-25 | |
| 2022-12-31 | $47.00M 10-K · filed 2025-02-12 | |
| 2022-09-30 | $45.00M 10-Q · filed 2023-10-26 | |
| 2022-06-30 | $71.00M 10-Q · filed 2023-07-27 | |
| 2022-03-31 | $102.00M 10-Q · filed 2023-04-27 | |
| 2021-12-31 | $101.00M 10-K · filed 2024-02-13 | |
| 2021-09-30 | $112.00M 10-Q · filed 2022-10-26 | |
| 2021-06-30 | $126.00M 10-Q · filed 2022-07-27 | |
| 2021-03-31 | $126.00M 10-Q · filed 2022-04-29 | |
| 2021-01-01 | $148.00M 10-Q · filed 2021-10-27 | |
| 2020-12-31 | $148.00M 10-K · filed 2023-02-14 | |
| 2020-09-30 | $194.00M 10-Q · filed 2021-10-27 | |
| 2020-06-30 | $141.00M 10-Q · filed 2021-07-28 | |
| 2020-03-31 | $141.00M 10-Q · filed 2021-04-29 | |
| 2020-01-01 | $100.00M 10-Q · filed 2021-10-27 | |
| 2019-12-31 | $100.00M 10-K · filed 2022-02-09 | |
| 2019-09-30 | $29.00M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $44.00M 10-Q · filed 2019-07-25 | |
| 2019-03-31 | $63.00M 10-Q · filed 2019-04-25 | |
| 2019-01-01 | $96.00M 10-K · filed 2021-02-10 | |
| 2018-12-31 | $96.00M 10-K · filed 2022-02-09 | $99.00M 10-K · filed 2019-02-25 |
| 2018-09-30 | $119.00M 10-Q · filed 2019-10-31 | |
| 2018-06-30 | $115.00M 10-Q · filed 2019-07-25 | |
| 2018-03-31 | $136.00M 10-Q · filed 2019-04-25 | |
| 2018-01-01 | $186.00M 10-K · filed 2021-02-10 | |
| 2017-12-31 | $186.00M 10-K · filed 2021-02-10 | |
| 2017-09-30 | $159.00M 10-Q · filed 2018-10-25 | |
| 2017-06-30 | $198.00M 10-Q · filed 2018-07-26 | |
| 2017-03-31 | $235.00M 10-Q · filed 2018-04-26 | |
| 2017-01-01 | $114.00M 10-Q · filed 2018-10-25 | |
| 2016-12-31 | $114.00M 10-K · filed 2019-02-25 | |
| 2016-09-30 | $80.00M 10-Q · filed 2017-10-26 | |
| 2016-06-30 | $85.00M 10-Q · filed 2017-07-27 | |
| 2016-03-31 | $96.00M 10-Q · filed 2017-04-27 | |
| 2015-12-31 | $125.00M 10-K · filed 2019-02-25 | |
| 2015-09-30 | $95.00M 10-Q · filed 2015-10-27 | |
| 2015-06-30 | $107.00M 10-Q · filed 2015-07-23 | |
| 2015-03-31 | $112.00M 10-Q · filed 2015-04-28 | |
| 2014-12-31 | $156.00M 10-K · filed 2018-02-13 | |
| 2014-09-30 | $100.00M 10-Q · filed 2015-10-27 | |
| 2014-06-30 | $92.00M 10-Q · filed 2015-07-23 | |
| 2014-03-31 | $97.00M 10-Q · filed 2015-04-28 | |
| 2013-12-31 | $102.00M 10-K · filed 2017-02-21 | |
| 2013-09-30 | $190.00M 10-Q · filed 2014-10-24 | |
| 2013-06-30 | $244.00M 10-Q · filed 2014-07-24 | |
| 2013-03-31 | $142.00M 10-Q · filed 2014-04-29 | |
| 2012-12-31 | $167.00M 10-K · filed 2016-02-12 | |
| 2012-09-30 | $107.00M 10-Q · filed 2013-10-23 | |
| 2012-06-30 | $74.00M 10-Q · filed 2013-07-25 | |
| 2012-03-31 | $78.00M 10-Q · filed 2013-04-25 | |
| 2011-12-31 | $77.00M 10-K · filed 2015-02-13 | |
| 2011-09-30 | $100.00M 10-Q · filed 2012-10-24 | |
| 2011-06-30 | $128.00M 10-Q · filed 2012-07-25 | |
| 2011-03-31 | $135.00M 10-Q · filed 2012-04-26 | |
| 2010-12-31 | $126.00M 10-K · filed 2014-02-14 | |
| 2010-09-30 | $126.00M 10-Q · filed 2011-10-27 | |
| 2010-06-30 | $133.00M 10-Q · filed 2011-07-28 | |
| 2010-03-31 | $151.00M 10-Q · filed 2011-04-28 | |
| 2009-12-31 | $173.00M 10-K · filed 2013-02-15 | |
| 2009-09-30 | $188.00M 10-Q · filed 2010-10-26 | |
| 2009-06-30 | $177.00M 10-Q · filed 2010-07-22 | |
| 2008-12-31 | $209.00M 10-K · filed 2012-02-17 | |
| 2007-12-31 | $167.00M 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |